nodes	percent_of_prediction	percent_of_DWPC	metapath
Nateglinide—L-Phenylalanine—Melphalan—breast cancer	0.116	1	CrCrCtD
Nateglinide—PTGS1—breast cancer	0.103	0.36	CbGaD
Nateglinide—CYP2D6—breast cancer	0.0698	0.245	CbGaD
Nateglinide—CYP3A4—breast cancer	0.0599	0.21	CbGaD
Nateglinide—ALB—breast cancer	0.0523	0.184	CbGaD
Nateglinide—UGT1A9—Irinotecan—breast cancer	0.0239	0.0654	CbGbCtD
Nateglinide—SLC16A1—Methotrexate—breast cancer	0.022	0.0602	CbGbCtD
Nateglinide—ABCC4—Fluorouracil—breast cancer	0.0192	0.0525	CbGbCtD
Nateglinide—CYP2C9—Anastrozole—breast cancer	0.0155	0.0426	CbGbCtD
Nateglinide—CYP3A5—Lapatinib—breast cancer	0.0155	0.0424	CbGbCtD
Nateglinide—CYP3A4—Exemestane—breast cancer	0.0119	0.0327	CbGbCtD
Nateglinide—CYP2C9—Idarubicin—breast cancer	0.0118	0.0323	CbGbCtD
Nateglinide—CYP2D6—Idarubicin—breast cancer	0.0108	0.0295	CbGbCtD
Nateglinide—ABCC4—Methotrexate—breast cancer	0.0106	0.0289	CbGbCtD
Nateglinide—CYP3A7-CYP3A51P—Tamoxifen—breast cancer	0.0103	0.0283	CbGbCtD
Nateglinide—CYP3A7—Tamoxifen—breast cancer	0.0103	0.0283	CbGbCtD
Nateglinide—CYP3A4—Letrozole—breast cancer	0.0101	0.0278	CbGbCtD
Nateglinide—CYP3A4—Anastrozole—breast cancer	0.00904	0.0248	CbGbCtD
Nateglinide—CYP3A4—Toremifene—breast cancer	0.00827	0.0226	CbGbCtD
Nateglinide—CYP3A7—Paclitaxel—breast cancer	0.00804	0.022	CbGbCtD
Nateglinide—CYP3A7-CYP3A51P—Paclitaxel—breast cancer	0.00804	0.022	CbGbCtD
Nateglinide—CYP3A7-CYP3A51P—Irinotecan—breast cancer	0.00793	0.0217	CbGbCtD
Nateglinide—CYP3A7—Irinotecan—breast cancer	0.00793	0.0217	CbGbCtD
Nateglinide—CYP3A5—Tamoxifen—breast cancer	0.00774	0.0212	CbGbCtD
Nateglinide—CYP3A4—Fulvestrant—breast cancer	0.00769	0.0211	CbGbCtD
Nateglinide—ALB—Irinotecan—breast cancer	0.0074	0.0203	CbGbCtD
Nateglinide—ALB—Fluorouracil—breast cancer	0.0071	0.0195	CbGbCtD
Nateglinide—CYP3A4—Thiotepa—breast cancer	0.00685	0.0188	CbGbCtD
Nateglinide—CYP2C9—Capecitabine—breast cancer	0.00646	0.0177	CbGbCtD
Nateglinide—CYP3A4—Ixabepilone—breast cancer	0.00627	0.0172	CbGbCtD
Nateglinide—CYP3A4—Lapatinib—breast cancer	0.00603	0.0165	CbGbCtD
Nateglinide—CYP3A5—Paclitaxel—breast cancer	0.00603	0.0165	CbGbCtD
Nateglinide—CYP3A5—Irinotecan—breast cancer	0.00595	0.0163	CbGbCtD
Nateglinide—CYP3A7—Docetaxel—breast cancer	0.00581	0.0159	CbGbCtD
Nateglinide—CYP3A7-CYP3A51P—Docetaxel—breast cancer	0.00581	0.0159	CbGbCtD
Nateglinide—CYP2D6—Vinorelbine—breast cancer	0.00526	0.0144	CbGbCtD
Nateglinide—CYP2C9—Tamoxifen—breast cancer	0.00519	0.0142	CbGbCtD
Nateglinide—CYP2D6—Tamoxifen—breast cancer	0.00475	0.013	CbGbCtD
Nateglinide—SLC22A6—Methotrexate—breast cancer	0.0046	0.0126	CbGbCtD
Nateglinide—CYP3A4—Raloxifene—breast cancer	0.00457	0.0125	CbGbCtD
Nateglinide—CYP3A5—Docetaxel—breast cancer	0.00436	0.0119	CbGbCtD
Nateglinide—CYP2C9—Paclitaxel—breast cancer	0.00404	0.0111	CbGbCtD
Nateglinide—ALB—Methotrexate—breast cancer	0.00392	0.0107	CbGbCtD
Nateglinide—CYP2C9—Fluorouracil—breast cancer	0.00383	0.0105	CbGbCtD
Nateglinide—CYP3A4—Vinorelbine—breast cancer	0.00335	0.00916	CbGbCtD
Nateglinide—CYP2D6—Vinblastine—breast cancer	0.00324	0.00888	CbGbCtD
Nateglinide—CYP3A4—Tamoxifen—breast cancer	0.00302	0.00827	CbGbCtD
Nateglinide—CYP3A4—Mitoxantrone—breast cancer	0.00295	0.00807	CbGbCtD
Nateglinide—CYP3A4—Paclitaxel—breast cancer	0.00235	0.00644	CbGbCtD
Nateglinide—CYP3A4—Irinotecan—breast cancer	0.00232	0.00635	CbGbCtD
Nateglinide—CYP3A4—Vinblastine—breast cancer	0.00206	0.00565	CbGbCtD
Nateglinide—CYP2D6—Doxorubicin—breast cancer	0.00199	0.00546	CbGbCtD
Nateglinide—CYP3A4—Docetaxel—breast cancer	0.0017	0.00466	CbGbCtD
Nateglinide—PPARG—Topotecan—Irinotecan—breast cancer	0.00151	1	CbGdCrCtD
Nateglinide—CYP3A4—Doxorubicin—breast cancer	0.00127	0.00347	CbGbCtD
Nateglinide—KCNJ11—mammary gland—breast cancer	0.00119	0.0383	CbGeAlD
Nateglinide—ABCC8—mammary gland—breast cancer	0.0011	0.0353	CbGeAlD
Nateglinide—PPARG—mammary gland—breast cancer	0.000839	0.0269	CbGeAlD
Nateglinide—ALB—mammary gland—breast cancer	0.000787	0.0253	CbGeAlD
Nateglinide—PPARG—nipple—breast cancer	0.000694	0.0223	CbGeAlD
Nateglinide—SLC15A2—mammary gland—breast cancer	0.000657	0.0211	CbGeAlD
Nateglinide—UGT1A9—endocrine gland—breast cancer	0.000597	0.0192	CbGeAlD
Nateglinide—SLC15A1—epithelium—breast cancer	0.000585	0.0188	CbGeAlD
Nateglinide—PPARG—embryo—breast cancer	0.000572	0.0184	CbGeAlD
Nateglinide—SLC16A1—epithelium—breast cancer	0.000557	0.0179	CbGeAlD
Nateglinide—ABCC8—endometrium—breast cancer	0.000549	0.0176	CbGeAlD
Nateglinide—SLC15A1—endometrium—breast cancer	0.000524	0.0169	CbGeAlD
Nateglinide—SLC16A1—endometrium—breast cancer	0.000499	0.016	CbGeAlD
Nateglinide—ABCC8—pituitary gland—breast cancer	0.000496	0.016	CbGeAlD
Nateglinide—CYP3A7—endocrine gland—breast cancer	0.000496	0.0159	CbGeAlD
Nateglinide—KCNJ11—female reproductive system—breast cancer	0.000493	0.0159	CbGeAlD
Nateglinide—CYP2C9—mammary gland—breast cancer	0.000491	0.0158	CbGeAlD
Nateglinide—KCNJ11—adrenal gland—breast cancer	0.000482	0.0155	CbGeAlD
Nateglinide—PPARG—epithelium—breast cancer	0.000467	0.015	CbGeAlD
Nateglinide—SLC16A1—uterus—breast cancer	0.00046	0.0148	CbGeAlD
Nateglinide—SLC16A1—pituitary gland—breast cancer	0.000452	0.0145	CbGeAlD
Nateglinide—SLC16A1—adipose tissue—breast cancer	0.00045	0.0145	CbGeAlD
Nateglinide—KCNJ11—female gonad—breast cancer	0.000449	0.0144	CbGeAlD
Nateglinide—ORM1—endometrium—breast cancer	0.000448	0.0144	CbGeAlD
Nateglinide—PPARG—skin of body—breast cancer	0.000444	0.0143	CbGeAlD
Nateglinide—ABCC8—adrenal gland—breast cancer	0.000444	0.0143	CbGeAlD
Nateglinide—KCNJ11—endocrine gland—breast cancer	0.000418	0.0134	CbGeAlD
Nateglinide—SLC16A1—female reproductive system—breast cancer	0.000413	0.0133	CbGeAlD
Nateglinide—SLC16A1—adrenal gland—breast cancer	0.000403	0.013	CbGeAlD
Nateglinide—PPARG—uterus—breast cancer	0.000386	0.0124	CbGeAlD
Nateglinide—ABCC8—endocrine gland—breast cancer	0.000385	0.0124	CbGeAlD
Nateglinide—PPARG—adipose tissue—breast cancer	0.000377	0.0121	CbGeAlD
Nateglinide—SLC16A1—female gonad—breast cancer	0.000376	0.0121	CbGeAlD
Nateglinide—ORM1—female reproductive system—breast cancer	0.000371	0.0119	CbGeAlD
Nateglinide—PTGS1—nipple—breast cancer	0.000371	0.0119	CbGeAlD
Nateglinide—SLC15A1—endocrine gland—breast cancer	0.000368	0.0118	CbGeAlD
Nateglinide—ABCC4—uterus—breast cancer	0.00035	0.0113	CbGeAlD
Nateglinide—ORM1—bone marrow—breast cancer	0.00035	0.0113	CbGeAlD
Nateglinide—SLC16A1—endocrine gland—breast cancer	0.00035	0.0112	CbGeAlD
Nateglinide—PPARG—female reproductive system—breast cancer	0.000347	0.0111	CbGeAlD
Nateglinide—ABCC4—adipose tissue—breast cancer	0.000343	0.011	CbGeAlD
Nateglinide—PPARG—adrenal gland—breast cancer	0.000339	0.0109	CbGeAlD
Nateglinide—SLC15A2—endometrium—breast cancer	0.000328	0.0105	CbGeAlD
Nateglinide—PPARG—bone marrow—breast cancer	0.000328	0.0105	CbGeAlD
Nateglinide—ALB—adrenal gland—breast cancer	0.000318	0.0102	CbGeAlD
Nateglinide—PPARG—female gonad—breast cancer	0.000316	0.0101	CbGeAlD
Nateglinide—ABCC4—female reproductive system—breast cancer	0.000315	0.0101	CbGeAlD
Nateglinide—ORM1—endocrine gland—breast cancer	0.000314	0.0101	CbGeAlD
Nateglinide—ABCC4—adrenal gland—breast cancer	0.000307	0.00988	CbGeAlD
Nateglinide—ABCC4—bone marrow—breast cancer	0.000297	0.00956	CbGeAlD
Nateglinide—SLC15A2—pituitary gland—breast cancer	0.000297	0.00953	CbGeAlD
Nateglinide—PPARG—endocrine gland—breast cancer	0.000294	0.00943	CbGeAlD
Nateglinide—KCNJ11—lymph node—breast cancer	0.000289	0.00927	CbGeAlD
Nateglinide—ABCC4—female gonad—breast cancer	0.000287	0.00921	CbGeAlD
Nateglinide—Lacosamide—SCN10A—breast cancer	0.000278	0.137	CrCbGaD
Nateglinide—SLC15A2—female reproductive system—breast cancer	0.000272	0.00873	CbGeAlD
Nateglinide—ABCC4—endocrine gland—breast cancer	0.000267	0.00857	CbGeAlD
Nateglinide—SLC15A2—adrenal gland—breast cancer	0.000265	0.00852	CbGeAlD
Nateglinide—Lacosamide—CA9—breast cancer	0.000254	0.126	CrCbGaD
Nateglinide—Ramipril—BCHE—breast cancer	0.000253	0.125	CrCbGaD
Nateglinide—PTGS1—epithelium—breast cancer	0.00025	0.00802	CbGeAlD
Nateglinide—SLC15A2—female gonad—breast cancer	0.000247	0.00794	CbGeAlD
Nateglinide—SLC16A1—lymph node—breast cancer	0.000242	0.00777	CbGeAlD
Nateglinide—PTGS1—skin of body—breast cancer	0.000237	0.00763	CbGeAlD
Nateglinide—SLC15A2—endocrine gland—breast cancer	0.00023	0.00739	CbGeAlD
Nateglinide—CYP3A5—adipose tissue—breast cancer	0.000225	0.00722	CbGeAlD
Nateglinide—PTGS1—endometrium—breast cancer	0.000224	0.00719	CbGeAlD
Nateglinide—ORM1—lymph node—breast cancer	0.000217	0.00698	CbGeAlD
Nateglinide—PTGS1—uterus—breast cancer	0.000206	0.00663	CbGeAlD
Nateglinide—Bortezomib—PTGS1—breast cancer	0.000206	0.102	CrCbGaD
Nateglinide—CYP2C9—female reproductive system—breast cancer	0.000203	0.00653	CbGeAlD
Nateglinide—PPARG—lymph node—breast cancer	0.000203	0.00652	CbGeAlD
Nateglinide—PTGS1—pituitary gland—breast cancer	0.000203	0.00651	CbGeAlD
Nateglinide—PTGS1—adipose tissue—breast cancer	0.000202	0.00648	CbGeAlD
Nateglinide—ALB—lymph node—breast cancer	0.00019	0.00612	CbGeAlD
Nateglinide—Bortezomib—CYP1A1—breast cancer	0.000188	0.0931	CrCbGaD
Nateglinide—CYP3A5—female gonad—breast cancer	0.000188	0.00604	CbGeAlD
Nateglinide—PTGS1—female reproductive system—breast cancer	0.000185	0.00596	CbGeAlD
Nateglinide—ABCC4—lymph node—breast cancer	0.000184	0.00592	CbGeAlD
Nateglinide—PTGS1—adrenal gland—breast cancer	0.000181	0.00582	CbGeAlD
Nateglinide—CYP3A5—endocrine gland—breast cancer	0.000175	0.00561	CbGeAlD
Nateglinide—CYP2C9—endocrine gland—breast cancer	0.000172	0.00552	CbGeAlD
Nateglinide—PTGS1—female gonad—breast cancer	0.000169	0.00542	CbGeAlD
Nateglinide—SLC15A2—lymph node—breast cancer	0.000159	0.00511	CbGeAlD
Nateglinide—PTGS1—endocrine gland—breast cancer	0.000157	0.00504	CbGeAlD
Nateglinide—CYP3A4—female reproductive system—breast cancer	0.000155	0.00498	CbGeAlD
Nateglinide—CYP2D6—female reproductive system—breast cancer	0.000152	0.0049	CbGeAlD
Nateglinide—Bortezomib—CYP2D6—breast cancer	0.00014	0.0693	CrCbGaD
Nateglinide—CYP2D6—female gonad—breast cancer	0.000139	0.00446	CbGeAlD
Nateglinide—CYP3A4—endocrine gland—breast cancer	0.000131	0.00421	CbGeAlD
Nateglinide—CYP2D6—endocrine gland—breast cancer	0.000129	0.00415	CbGeAlD
Nateglinide—Bortezomib—CYP3A4—breast cancer	0.00012	0.0594	CrCbGaD
Nateglinide—Gastrointestinal pain—Vinorelbine—breast cancer	0.000112	0.00104	CcSEcCtD
Nateglinide—Pruritus—Melphalan—breast cancer	0.000111	0.00103	CcSEcCtD
Nateglinide—Hypoglycaemia—Epirubicin—breast cancer	0.00011	0.00102	CcSEcCtD
Nateglinide—Asthenia—Goserelin—breast cancer	0.00011	0.00102	CcSEcCtD
Nateglinide—Diarrhoea—Tamoxifen—breast cancer	0.000109	0.00101	CcSEcCtD
Nateglinide—Hyperhidrosis—Mitoxantrone—breast cancer	0.000109	0.00101	CcSEcCtD
Nateglinide—Hyperhidrosis—Irinotecan—breast cancer	0.000109	0.00101	CcSEcCtD
Nateglinide—Back pain—Paclitaxel—breast cancer	0.000109	0.00101	CcSEcCtD
Nateglinide—Dizziness—Vinblastine—breast cancer	0.000109	0.00101	CcSEcCtD
Nateglinide—Urticaria—Vinorelbine—breast cancer	0.000109	0.00101	CcSEcCtD
Nateglinide—PTGS1—lymph node—breast cancer	0.000108	0.00349	CbGeAlD
Nateglinide—Abdominal pain—Vinorelbine—breast cancer	0.000108	0.001	CcSEcCtD
Nateglinide—Oedema peripheral—Docetaxel—breast cancer	0.000108	0.001	CcSEcCtD
Nateglinide—Pruritus—Goserelin—breast cancer	0.000108	0.001	CcSEcCtD
Nateglinide—Diarrhoea—Melphalan—breast cancer	0.000107	0.000992	CcSEcCtD
Nateglinide—Osteoarthritis—Epirubicin—breast cancer	0.000107	0.000991	CcSEcCtD
Nateglinide—Gastrointestinal pain—Thiotepa—breast cancer	0.000107	0.000989	CcSEcCtD
Nateglinide—Nausea—Chlorambucil—breast cancer	0.000107	0.000988	CcSEcCtD
Nateglinide—Hyperhidrosis—Gemcitabine—breast cancer	0.000106	0.000984	CcSEcCtD
Nateglinide—Dizziness—Tamoxifen—breast cancer	0.000106	0.000979	CcSEcCtD
Nateglinide—Tremor—Paclitaxel—breast cancer	0.000106	0.000978	CcSEcCtD
Nateglinide—Increased appetite—Doxorubicin—breast cancer	0.000105	0.000976	CcSEcCtD
Nateglinide—Oedema peripheral—Capecitabine—breast cancer	0.000105	0.00097	CcSEcCtD
Nateglinide—Vomiting—Vinblastine—breast cancer	0.000105	0.000969	CcSEcCtD
Nateglinide—Diarrhoea—Goserelin—breast cancer	0.000105	0.000968	CcSEcCtD
Nateglinide—Erythema multiforme—Docetaxel—breast cancer	0.000104	0.000961	CcSEcCtD
Nateglinide—Urticaria—Thiotepa—breast cancer	0.000104	0.000961	CcSEcCtD
Nateglinide—Abdominal pain—Thiotepa—breast cancer	0.000103	0.000957	CcSEcCtD
Nateglinide—Lisinopril—ABCB1—breast cancer	0.000103	0.0507	CrCbGaD
Nateglinide—Cilazapril—ABCB1—breast cancer	0.000103	0.0507	CrCbGaD
Nateglinide—Vomiting—Tamoxifen—breast cancer	0.000102	0.000942	CcSEcCtD
Nateglinide—Hypoglycaemia—Doxorubicin—breast cancer	0.000101	0.00094	CcSEcCtD
Nateglinide—Dizziness—Goserelin—breast cancer	0.000101	0.000936	CcSEcCtD
Nateglinide—Rash—Tamoxifen—breast cancer	0.000101	0.000934	CcSEcCtD
Nateglinide—Hypersensitivity—Vinorelbine—breast cancer	0.000101	0.000934	CcSEcCtD
Nateglinide—Dermatitis—Tamoxifen—breast cancer	0.000101	0.000933	CcSEcCtD
Nateglinide—Erythema multiforme—Capecitabine—breast cancer	0.0001	0.000931	CcSEcCtD
Nateglinide—Palpitations—Paclitaxel—breast cancer	9.96e-05	0.000923	CcSEcCtD
Nateglinide—Vomiting—Melphalan—breast cancer	9.96e-05	0.000922	CcSEcCtD
Nateglinide—Dyspepsia—Mitoxantrone—breast cancer	9.93e-05	0.00092	CcSEcCtD
Nateglinide—Dyspepsia—Irinotecan—breast cancer	9.93e-05	0.00092	CcSEcCtD
Nateglinide—Immune system disorder—Docetaxel—breast cancer	9.92e-05	0.000918	CcSEcCtD
Nateglinide—Osteoarthritis—Doxorubicin—breast cancer	9.9e-05	0.000917	CcSEcCtD
Nateglinide—Rash—Melphalan—breast cancer	9.87e-05	0.000914	CcSEcCtD
Nateglinide—Dermatitis—Melphalan—breast cancer	9.86e-05	0.000914	CcSEcCtD
Nateglinide—Cough—Paclitaxel—breast cancer	9.84e-05	0.000911	CcSEcCtD
Nateglinide—Asthenia—Vinorelbine—breast cancer	9.82e-05	0.000909	CcSEcCtD
Nateglinide—Nausea—Vinblastine—breast cancer	9.78e-05	0.000906	CcSEcCtD
Nateglinide—Gastrointestinal disorder—Irinotecan—breast cancer	9.74e-05	0.000902	CcSEcCtD
Nateglinide—Fatigue—Mitoxantrone—breast cancer	9.73e-05	0.000901	CcSEcCtD
Nateglinide—Fatigue—Irinotecan—breast cancer	9.73e-05	0.000901	CcSEcCtD
Nateglinide—Vomiting—Goserelin—breast cancer	9.71e-05	0.000899	CcSEcCtD
Nateglinide—Pruritus—Vinorelbine—breast cancer	9.68e-05	0.000896	CcSEcCtD
Nateglinide—Rash—Goserelin—breast cancer	9.63e-05	0.000892	CcSEcCtD
Nateglinide—Hypersensitivity—Thiotepa—breast cancer	9.63e-05	0.000892	CcSEcCtD
Nateglinide—Dermatitis—Goserelin—breast cancer	9.62e-05	0.000891	CcSEcCtD
Nateglinide—Immune system disorder—Capecitabine—breast cancer	9.6e-05	0.000889	CcSEcCtD
Nateglinide—Malnutrition—Docetaxel—breast cancer	9.56e-05	0.000885	CcSEcCtD
Nateglinide—Dyspepsia—Fluorouracil—breast cancer	9.51e-05	0.000881	CcSEcCtD
Nateglinide—Nausea—Tamoxifen—breast cancer	9.5e-05	0.00088	CcSEcCtD
Nateglinide—Gastrointestinal disorder—Gemcitabine—breast cancer	9.49e-05	0.000879	CcSEcCtD
Nateglinide—Fatigue—Gemcitabine—breast cancer	9.48e-05	0.000878	CcSEcCtD
Nateglinide—Asthenia—Thiotepa—breast cancer	9.37e-05	0.000868	CcSEcCtD
Nateglinide—Diarrhoea—Vinorelbine—breast cancer	9.36e-05	0.000867	CcSEcCtD
Nateglinide—Gastrointestinal disorder—Fluorouracil—breast cancer	9.33e-05	0.000864	CcSEcCtD
Nateglinide—Nausea—Melphalan—breast cancer	9.3e-05	0.000861	CcSEcCtD
Nateglinide—Malnutrition—Capecitabine—breast cancer	9.25e-05	0.000857	CcSEcCtD
Nateglinide—Influenza—Epirubicin—breast cancer	9.25e-05	0.000857	CcSEcCtD
Nateglinide—Back pain—Docetaxel—breast cancer	9.24e-05	0.000856	CcSEcCtD
Nateglinide—Pruritus—Thiotepa—breast cancer	9.24e-05	0.000856	CcSEcCtD
Nateglinide—Gastrointestinal pain—Mitoxantrone—breast cancer	9.23e-05	0.000855	CcSEcCtD
Nateglinide—Gastrointestinal pain—Irinotecan—breast cancer	9.23e-05	0.000855	CcSEcCtD
Nateglinide—Upper respiratory tract infection—Methotrexate—breast cancer	9.19e-05	0.000851	CcSEcCtD
Nateglinide—Nausea—Goserelin—breast cancer	9.07e-05	0.00084	CcSEcCtD
Nateglinide—Dizziness—Vinorelbine—breast cancer	9.05e-05	0.000838	CcSEcCtD
Nateglinide—Enalapril—CYP3A4—breast cancer	9.04e-05	0.0447	CrCbGaD
Nateglinide—Urticaria—Mitoxantrone—breast cancer	8.96e-05	0.00083	CcSEcCtD
Nateglinide—Back pain—Capecitabine—breast cancer	8.95e-05	0.000829	CcSEcCtD
Nateglinide—Diarrhoea—Thiotepa—breast cancer	8.94e-05	0.000828	CcSEcCtD
Nateglinide—Abdominal pain—Irinotecan—breast cancer	8.92e-05	0.000826	CcSEcCtD
Nateglinide—Abdominal pain—Mitoxantrone—breast cancer	8.92e-05	0.000826	CcSEcCtD
Nateglinide—Bronchitis—Epirubicin—breast cancer	8.9e-05	0.000824	CcSEcCtD
Nateglinide—Hyperhidrosis—Paclitaxel—breast cancer	8.9e-05	0.000824	CcSEcCtD
Nateglinide—Vomiting—Vinorelbine—breast cancer	8.7e-05	0.000806	CcSEcCtD
Nateglinide—Tremor—Capecitabine—breast cancer	8.67e-05	0.000803	CcSEcCtD
Nateglinide—Dizziness—Thiotepa—breast cancer	8.64e-05	0.0008	CcSEcCtD
Nateglinide—Rash—Vinorelbine—breast cancer	8.63e-05	0.000799	CcSEcCtD
Nateglinide—Dermatitis—Vinorelbine—breast cancer	8.62e-05	0.000798	CcSEcCtD
Nateglinide—Upper respiratory tract infection—Epirubicin—breast cancer	8.6e-05	0.000796	CcSEcCtD
Nateglinide—Urticaria—Fluorouracil—breast cancer	8.58e-05	0.000795	CcSEcCtD
Nateglinide—Influenza—Doxorubicin—breast cancer	8.56e-05	0.000793	CcSEcCtD
Nateglinide—Sweating—Methotrexate—breast cancer	8.45e-05	0.000783	CcSEcCtD
Nateglinide—Palpitations—Docetaxel—breast cancer	8.45e-05	0.000782	CcSEcCtD
Nateglinide—Cough—Docetaxel—breast cancer	8.34e-05	0.000772	CcSEcCtD
Nateglinide—Hepatobiliary disease—Methotrexate—breast cancer	8.34e-05	0.000772	CcSEcCtD
Nateglinide—Hypersensitivity—Mitoxantrone—breast cancer	8.31e-05	0.00077	CcSEcCtD
Nateglinide—Hypersensitivity—Irinotecan—breast cancer	8.31e-05	0.00077	CcSEcCtD
Nateglinide—Vomiting—Thiotepa—breast cancer	8.31e-05	0.000769	CcSEcCtD
Nateglinide—Dextroamphetamine—CYP2D6—breast cancer	8.3e-05	0.041	CrCbGaD
Nateglinide—Rash—Thiotepa—breast cancer	8.24e-05	0.000763	CcSEcCtD
Nateglinide—Bronchitis—Doxorubicin—breast cancer	8.23e-05	0.000762	CcSEcCtD
Nateglinide—Dermatitis—Thiotepa—breast cancer	8.23e-05	0.000762	CcSEcCtD
Nateglinide—Palpitations—Capecitabine—breast cancer	8.18e-05	0.000757	CcSEcCtD
Nateglinide—Nausea—Vinorelbine—breast cancer	8.13e-05	0.000753	CcSEcCtD
Nateglinide—Dyspepsia—Paclitaxel—breast cancer	8.1e-05	0.00075	CcSEcCtD
Nateglinide—Asthenia—Irinotecan—breast cancer	8.1e-05	0.00075	CcSEcCtD
Nateglinide—Asthenia—Mitoxantrone—breast cancer	8.1e-05	0.00075	CcSEcCtD
Nateglinide—Neuropathy peripheral—Epirubicin—breast cancer	8.09e-05	0.000749	CcSEcCtD
Nateglinide—Cough—Capecitabine—breast cancer	8.07e-05	0.000748	CcSEcCtD
Nateglinide—Jaundice—Epirubicin—breast cancer	8.04e-05	0.000745	CcSEcCtD
Nateglinide—Hypersensitivity—Fluorouracil—breast cancer	7.96e-05	0.000737	CcSEcCtD
Nateglinide—Upper respiratory tract infection—Doxorubicin—breast cancer	7.96e-05	0.000737	CcSEcCtD
Nateglinide—Gastrointestinal disorder—Paclitaxel—breast cancer	7.94e-05	0.000736	CcSEcCtD
Nateglinide—Fatigue—Paclitaxel—breast cancer	7.93e-05	0.000735	CcSEcCtD
Nateglinide—Sweating—Epirubicin—breast cancer	7.91e-05	0.000732	CcSEcCtD
Nateglinide—Asthenia—Gemcitabine—breast cancer	7.89e-05	0.00073	CcSEcCtD
Nateglinide—Hepatobiliary disease—Epirubicin—breast cancer	7.8e-05	0.000723	CcSEcCtD
Nateglinide—Pruritus—Gemcitabine—breast cancer	7.78e-05	0.00072	CcSEcCtD
Nateglinide—Nausea—Thiotepa—breast cancer	7.76e-05	0.000719	CcSEcCtD
Nateglinide—Diarrhoea—Mitoxantrone—breast cancer	7.72e-05	0.000715	CcSEcCtD
Nateglinide—Diarrhoea—Irinotecan—breast cancer	7.72e-05	0.000715	CcSEcCtD
Nateglinide—Pruritus—Fluorouracil—breast cancer	7.65e-05	0.000708	CcSEcCtD
Nateglinide—Enalapril—ABCB1—breast cancer	7.53e-05	0.0372	CrCbGaD
Nateglinide—Gastrointestinal pain—Paclitaxel—breast cancer	7.52e-05	0.000697	CcSEcCtD
Nateglinide—Diarrhoea—Gemcitabine—breast cancer	7.52e-05	0.000696	CcSEcCtD
Nateglinide—Erythema multiforme—Methotrexate—breast cancer	7.48e-05	0.000693	CcSEcCtD
Nateglinide—Neuropathy peripheral—Doxorubicin—breast cancer	7.48e-05	0.000693	CcSEcCtD
Nateglinide—Dizziness—Irinotecan—breast cancer	7.46e-05	0.000691	CcSEcCtD
Nateglinide—Jaundice—Doxorubicin—breast cancer	7.44e-05	0.000689	CcSEcCtD
Nateglinide—Diarrhoea—Fluorouracil—breast cancer	7.39e-05	0.000685	CcSEcCtD
Nateglinide—Sweating—Doxorubicin—breast cancer	7.32e-05	0.000678	CcSEcCtD
Nateglinide—Urticaria—Paclitaxel—breast cancer	7.31e-05	0.000677	CcSEcCtD
Nateglinide—Hyperhidrosis—Capecitabine—breast cancer	7.3e-05	0.000676	CcSEcCtD
Nateglinide—Oedema peripheral—Epirubicin—breast cancer	7.29e-05	0.000676	CcSEcCtD
Nateglinide—Abdominal pain—Paclitaxel—breast cancer	7.27e-05	0.000674	CcSEcCtD
Nateglinide—Hepatobiliary disease—Doxorubicin—breast cancer	7.22e-05	0.000669	CcSEcCtD
Nateglinide—Vomiting—Irinotecan—breast cancer	7.17e-05	0.000664	CcSEcCtD
Nateglinide—Vomiting—Mitoxantrone—breast cancer	7.17e-05	0.000664	CcSEcCtD
Nateglinide—Immune system disorder—Methotrexate—breast cancer	7.15e-05	0.000662	CcSEcCtD
Nateglinide—Dizziness—Fluorouracil—breast cancer	7.15e-05	0.000662	CcSEcCtD
Nateglinide—Rash—Mitoxantrone—breast cancer	7.11e-05	0.000659	CcSEcCtD
Nateglinide—Rash—Irinotecan—breast cancer	7.11e-05	0.000659	CcSEcCtD
Nateglinide—Dermatitis—Irinotecan—breast cancer	7.11e-05	0.000658	CcSEcCtD
Nateglinide—Dermatitis—Mitoxantrone—breast cancer	7.11e-05	0.000658	CcSEcCtD
Nateglinide—Erythema multiforme—Epirubicin—breast cancer	7e-05	0.000648	CcSEcCtD
Nateglinide—Vomiting—Gemcitabine—breast cancer	6.99e-05	0.000647	CcSEcCtD
Nateglinide—Rash—Gemcitabine—breast cancer	6.93e-05	0.000642	CcSEcCtD
Nateglinide—Dermatitis—Gemcitabine—breast cancer	6.92e-05	0.000641	CcSEcCtD
Nateglinide—Malnutrition—Methotrexate—breast cancer	6.89e-05	0.000638	CcSEcCtD
Nateglinide—Vomiting—Fluorouracil—breast cancer	6.87e-05	0.000636	CcSEcCtD
Nateglinide—Dyspepsia—Docetaxel—breast cancer	6.87e-05	0.000636	CcSEcCtD
Nateglinide—Rash—Fluorouracil—breast cancer	6.81e-05	0.000631	CcSEcCtD
Nateglinide—Dermatitis—Fluorouracil—breast cancer	6.81e-05	0.00063	CcSEcCtD
Nateglinide—Hypersensitivity—Paclitaxel—breast cancer	6.78e-05	0.000628	CcSEcCtD
Nateglinide—Oedema peripheral—Doxorubicin—breast cancer	6.75e-05	0.000625	CcSEcCtD
Nateglinide—Gastrointestinal disorder—Docetaxel—breast cancer	6.73e-05	0.000624	CcSEcCtD
Nateglinide—Fatigue—Docetaxel—breast cancer	6.72e-05	0.000623	CcSEcCtD
Nateglinide—Nausea—Irinotecan—breast cancer	6.7e-05	0.000621	CcSEcCtD
Nateglinide—Nausea—Mitoxantrone—breast cancer	6.7e-05	0.000621	CcSEcCtD
Nateglinide—Amphetamine—CYP2D6—breast cancer	6.69e-05	0.0331	CrCbGaD
Nateglinide—Immune system disorder—Epirubicin—breast cancer	6.69e-05	0.000619	CcSEcCtD
Nateglinide—Back pain—Methotrexate—breast cancer	6.66e-05	0.000617	CcSEcCtD
Nateglinide—Dyspepsia—Capecitabine—breast cancer	6.65e-05	0.000616	CcSEcCtD
Nateglinide—Asthenia—Paclitaxel—breast cancer	6.6e-05	0.000611	CcSEcCtD
Nateglinide—Nausea—Gemcitabine—breast cancer	6.53e-05	0.000605	CcSEcCtD
Nateglinide—Gastrointestinal disorder—Capecitabine—breast cancer	6.52e-05	0.000604	CcSEcCtD
Nateglinide—Fatigue—Capecitabine—breast cancer	6.51e-05	0.000603	CcSEcCtD
Nateglinide—Pruritus—Paclitaxel—breast cancer	6.51e-05	0.000603	CcSEcCtD
Nateglinide—Erythema multiforme—Doxorubicin—breast cancer	6.48e-05	0.0006	CcSEcCtD
Nateglinide—Malnutrition—Epirubicin—breast cancer	6.45e-05	0.000597	CcSEcCtD
Nateglinide—Nausea—Fluorouracil—breast cancer	6.42e-05	0.000594	CcSEcCtD
Nateglinide—Gastrointestinal pain—Docetaxel—breast cancer	6.38e-05	0.000591	CcSEcCtD
Nateglinide—Diarrhoea—Paclitaxel—breast cancer	6.3e-05	0.000583	CcSEcCtD
Nateglinide—Back pain—Epirubicin—breast cancer	6.24e-05	0.000577	CcSEcCtD
Nateglinide—Methamphetamine—CYP2D6—breast cancer	6.2e-05	0.0306	CrCbGaD
Nateglinide—Immune system disorder—Doxorubicin—breast cancer	6.19e-05	0.000573	CcSEcCtD
Nateglinide—Gastrointestinal pain—Capecitabine—breast cancer	6.18e-05	0.000572	CcSEcCtD
Nateglinide—Abdominal pain—Docetaxel—breast cancer	6.17e-05	0.000571	CcSEcCtD
Nateglinide—Dizziness—Paclitaxel—breast cancer	6.09e-05	0.000564	CcSEcCtD
Nateglinide—Cough—Methotrexate—breast cancer	6.01e-05	0.000557	CcSEcCtD
Nateglinide—Urticaria—Capecitabine—breast cancer	6e-05	0.000556	CcSEcCtD
Nateglinide—Abdominal pain—Capecitabine—breast cancer	5.97e-05	0.000553	CcSEcCtD
Nateglinide—Malnutrition—Doxorubicin—breast cancer	5.96e-05	0.000552	CcSEcCtD
Nateglinide—Vomiting—Paclitaxel—breast cancer	5.85e-05	0.000542	CcSEcCtD
Nateglinide—Rash—Paclitaxel—breast cancer	5.8e-05	0.000537	CcSEcCtD
Nateglinide—Dermatitis—Paclitaxel—breast cancer	5.8e-05	0.000537	CcSEcCtD
Nateglinide—Back pain—Doxorubicin—breast cancer	5.77e-05	0.000534	CcSEcCtD
Nateglinide—Hypersensitivity—Docetaxel—breast cancer	5.75e-05	0.000532	CcSEcCtD
Nateglinide—Palpitations—Epirubicin—breast cancer	5.7e-05	0.000528	CcSEcCtD
Nateglinide—Cough—Epirubicin—breast cancer	5.62e-05	0.000521	CcSEcCtD
Nateglinide—Asthenia—Docetaxel—breast cancer	5.6e-05	0.000518	CcSEcCtD
Nateglinide—Hypersensitivity—Capecitabine—breast cancer	5.56e-05	0.000515	CcSEcCtD
Nateglinide—Pruritus—Docetaxel—breast cancer	5.52e-05	0.000511	CcSEcCtD
Nateglinide—Nausea—Paclitaxel—breast cancer	5.47e-05	0.000506	CcSEcCtD
Nateglinide—Hyperhidrosis—Methotrexate—breast cancer	5.43e-05	0.000503	CcSEcCtD
Nateglinide—Asthenia—Capecitabine—breast cancer	5.42e-05	0.000502	CcSEcCtD
Nateglinide—Pruritus—Capecitabine—breast cancer	5.34e-05	0.000495	CcSEcCtD
Nateglinide—Diarrhoea—Docetaxel—breast cancer	5.34e-05	0.000494	CcSEcCtD
Nateglinide—Palpitations—Doxorubicin—breast cancer	5.27e-05	0.000488	CcSEcCtD
Nateglinide—Cough—Doxorubicin—breast cancer	5.2e-05	0.000482	CcSEcCtD
Nateglinide—Diarrhoea—Capecitabine—breast cancer	5.17e-05	0.000479	CcSEcCtD
Nateglinide—Dizziness—Docetaxel—breast cancer	5.16e-05	0.000478	CcSEcCtD
Nateglinide—Hyperhidrosis—Epirubicin—breast cancer	5.09e-05	0.000471	CcSEcCtD
Nateglinide—Dizziness—Capecitabine—breast cancer	4.99e-05	0.000462	CcSEcCtD
Nateglinide—Vomiting—Docetaxel—breast cancer	4.96e-05	0.000459	CcSEcCtD
Nateglinide—Dyspepsia—Methotrexate—breast cancer	4.95e-05	0.000458	CcSEcCtD
Nateglinide—Rash—Docetaxel—breast cancer	4.92e-05	0.000455	CcSEcCtD
Nateglinide—Dermatitis—Docetaxel—breast cancer	4.91e-05	0.000455	CcSEcCtD
Nateglinide—Gastrointestinal disorder—Methotrexate—breast cancer	4.85e-05	0.000449	CcSEcCtD
Nateglinide—Fatigue—Methotrexate—breast cancer	4.85e-05	0.000449	CcSEcCtD
Nateglinide—Vomiting—Capecitabine—breast cancer	4.8e-05	0.000445	CcSEcCtD
Nateglinide—Rash—Capecitabine—breast cancer	4.76e-05	0.000441	CcSEcCtD
Nateglinide—Dermatitis—Capecitabine—breast cancer	4.76e-05	0.000441	CcSEcCtD
Nateglinide—Hyperhidrosis—Doxorubicin—breast cancer	4.71e-05	0.000436	CcSEcCtD
Nateglinide—Nausea—Docetaxel—breast cancer	4.63e-05	0.000429	CcSEcCtD
Nateglinide—Dyspepsia—Epirubicin—breast cancer	4.63e-05	0.000429	CcSEcCtD
Nateglinide—Gastrointestinal pain—Methotrexate—breast cancer	4.6e-05	0.000426	CcSEcCtD
Nateglinide—Gastrointestinal disorder—Epirubicin—breast cancer	4.54e-05	0.000421	CcSEcCtD
Nateglinide—Fatigue—Epirubicin—breast cancer	4.54e-05	0.00042	CcSEcCtD
Nateglinide—Nausea—Capecitabine—breast cancer	4.49e-05	0.000415	CcSEcCtD
Nateglinide—Urticaria—Methotrexate—breast cancer	4.47e-05	0.000414	CcSEcCtD
Nateglinide—Abdominal pain—Methotrexate—breast cancer	4.44e-05	0.000412	CcSEcCtD
Nateglinide—Gastrointestinal pain—Epirubicin—breast cancer	4.3e-05	0.000398	CcSEcCtD
Nateglinide—Dyspepsia—Doxorubicin—breast cancer	4.28e-05	0.000397	CcSEcCtD
Nateglinide—Gastrointestinal disorder—Doxorubicin—breast cancer	4.2e-05	0.000389	CcSEcCtD
Nateglinide—Fatigue—Doxorubicin—breast cancer	4.2e-05	0.000389	CcSEcCtD
Nateglinide—Urticaria—Epirubicin—breast cancer	4.18e-05	0.000387	CcSEcCtD
Nateglinide—Abdominal pain—Epirubicin—breast cancer	4.16e-05	0.000385	CcSEcCtD
Nateglinide—Hypersensitivity—Methotrexate—breast cancer	4.14e-05	0.000384	CcSEcCtD
Nateglinide—Asthenia—Methotrexate—breast cancer	4.03e-05	0.000374	CcSEcCtD
Nateglinide—Gastrointestinal pain—Doxorubicin—breast cancer	3.98e-05	0.000369	CcSEcCtD
Nateglinide—Pruritus—Methotrexate—breast cancer	3.98e-05	0.000368	CcSEcCtD
Nateglinide—Hypersensitivity—Epirubicin—breast cancer	3.88e-05	0.000359	CcSEcCtD
Nateglinide—Urticaria—Doxorubicin—breast cancer	3.87e-05	0.000358	CcSEcCtD
Nateglinide—Abdominal pain—Doxorubicin—breast cancer	3.85e-05	0.000356	CcSEcCtD
Nateglinide—Diarrhoea—Methotrexate—breast cancer	3.85e-05	0.000356	CcSEcCtD
Nateglinide—Asthenia—Epirubicin—breast cancer	3.77e-05	0.00035	CcSEcCtD
Nateglinide—Pruritus—Epirubicin—breast cancer	3.72e-05	0.000345	CcSEcCtD
Nateglinide—Dizziness—Methotrexate—breast cancer	3.72e-05	0.000344	CcSEcCtD
Nateglinide—Diarrhoea—Epirubicin—breast cancer	3.6e-05	0.000333	CcSEcCtD
Nateglinide—Hypersensitivity—Doxorubicin—breast cancer	3.59e-05	0.000332	CcSEcCtD
Nateglinide—Vomiting—Methotrexate—breast cancer	3.57e-05	0.000331	CcSEcCtD
Nateglinide—Rash—Methotrexate—breast cancer	3.54e-05	0.000328	CcSEcCtD
Nateglinide—Dermatitis—Methotrexate—breast cancer	3.54e-05	0.000328	CcSEcCtD
Nateglinide—Asthenia—Doxorubicin—breast cancer	3.49e-05	0.000323	CcSEcCtD
Nateglinide—Dizziness—Epirubicin—breast cancer	3.48e-05	0.000322	CcSEcCtD
Nateglinide—Pruritus—Doxorubicin—breast cancer	3.44e-05	0.000319	CcSEcCtD
Nateglinide—Vomiting—Epirubicin—breast cancer	3.34e-05	0.00031	CcSEcCtD
Nateglinide—Nausea—Methotrexate—breast cancer	3.34e-05	0.000309	CcSEcCtD
Nateglinide—Diarrhoea—Doxorubicin—breast cancer	3.33e-05	0.000308	CcSEcCtD
Nateglinide—Rash—Epirubicin—breast cancer	3.32e-05	0.000307	CcSEcCtD
Nateglinide—Dermatitis—Epirubicin—breast cancer	3.31e-05	0.000307	CcSEcCtD
Nateglinide—Dizziness—Doxorubicin—breast cancer	3.22e-05	0.000298	CcSEcCtD
Nateglinide—Nausea—Epirubicin—breast cancer	3.12e-05	0.000289	CcSEcCtD
Nateglinide—Vomiting—Doxorubicin—breast cancer	3.09e-05	0.000287	CcSEcCtD
Nateglinide—Rash—Doxorubicin—breast cancer	3.07e-05	0.000284	CcSEcCtD
Nateglinide—Dermatitis—Doxorubicin—breast cancer	3.07e-05	0.000284	CcSEcCtD
Nateglinide—Nausea—Doxorubicin—breast cancer	2.89e-05	0.000268	CcSEcCtD
Nateglinide—ALB—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	2.51e-06	2.73e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—CYP3A4—breast cancer	2.5e-06	2.72e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—COMT—breast cancer	2.49e-06	2.72e-05	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—CAV1—breast cancer	2.49e-06	2.72e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	2.49e-06	2.71e-05	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—PIK3CB—breast cancer	2.48e-06	2.71e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—GSTP1—breast cancer	2.48e-06	2.7e-05	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—PTGS2—breast cancer	2.46e-06	2.68e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—CYP1B1—breast cancer	2.46e-06	2.68e-05	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—PIK3CD—breast cancer	2.45e-06	2.67e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—HMOX1—breast cancer	2.45e-06	2.67e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—PPARGC1B—breast cancer	2.44e-06	2.66e-05	CbGpPWpGaD
Nateglinide—ALB—Transmembrane transport of small molecules—RAF1—breast cancer	2.44e-06	2.66e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—ITPR1—breast cancer	2.44e-06	2.66e-05	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—ALB—breast cancer	2.42e-06	2.63e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—CYP17A1—breast cancer	2.41e-06	2.63e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—HSP90AA1—breast cancer	2.41e-06	2.63e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—CYP17A1—breast cancer	2.39e-06	2.6e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—ENO1—breast cancer	2.38e-06	2.6e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—PTGS1—breast cancer	2.38e-06	2.6e-05	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	2.38e-06	2.6e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—ENO1—breast cancer	2.36e-06	2.58e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—PTGS1—breast cancer	2.36e-06	2.58e-05	CbGpPWpGaD
Nateglinide—PPARG—Gene Expression—MAPK3—breast cancer	2.36e-06	2.57e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	2.36e-06	2.57e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—ABCB1—breast cancer	2.35e-06	2.56e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—NCOA1—breast cancer	2.34e-06	2.55e-05	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—PIK3CG—breast cancer	2.34e-06	2.55e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism of lipids and lipoproteins—ALB—breast cancer	2.33e-06	2.54e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—CYP2D6—breast cancer	2.32e-06	2.53e-05	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—NOS3—breast cancer	2.31e-06	2.52e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—STK11—breast cancer	2.31e-06	2.52e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—CYP19A1—breast cancer	2.31e-06	2.52e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—CA9—breast cancer	2.31e-06	2.52e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—GSTA4—breast cancer	2.31e-06	2.52e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—TYMS—breast cancer	2.31e-06	2.51e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—NCOA2—breast cancer	2.3e-06	2.5e-05	CbGpPWpGaD
Nateglinide—PPARG—Gene Expression—MYC—breast cancer	2.29e-06	2.5e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—GSTM1—breast cancer	2.28e-06	2.49e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—NCOR1—breast cancer	2.28e-06	2.49e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—PLA2G4A—breast cancer	2.28e-06	2.49e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—NCOA2—breast cancer	2.28e-06	2.48e-05	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—PIK3CG—breast cancer	2.27e-06	2.47e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—GPX2—breast cancer	2.25e-06	2.45e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—GSTA2—breast cancer	2.25e-06	2.45e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—FASN—breast cancer	2.23e-06	2.43e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—GPX4—breast cancer	2.22e-06	2.42e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—SULT1A1—breast cancer	2.22e-06	2.42e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—BCHE—breast cancer	2.22e-06	2.42e-05	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—SRC—breast cancer	2.21e-06	2.41e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—FASN—breast cancer	2.21e-06	2.41e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—BCHE—breast cancer	2.2e-06	2.4e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—SLC5A5—breast cancer	2.19e-06	2.39e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—GPX1—breast cancer	2.18e-06	2.38e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—SLC5A5—breast cancer	2.17e-06	2.37e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—IDH1—breast cancer	2.17e-06	2.37e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—GSTA1—breast cancer	2.17e-06	2.37e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism of lipids and lipoproteins—PTEN—breast cancer	2.17e-06	2.36e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—CYP1A1—breast cancer	2.16e-06	2.36e-05	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—VEGFA—breast cancer	2.15e-06	2.34e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—COMT—breast cancer	2.15e-06	2.34e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—NAT2—breast cancer	2.15e-06	2.34e-05	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—PTEN—breast cancer	2.15e-06	2.34e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—ERCC2—breast cancer	2.14e-06	2.34e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—GSTP1—breast cancer	2.14e-06	2.33e-05	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—PIK3CB—breast cancer	2.13e-06	2.33e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—SLC2A1—breast cancer	2.11e-06	2.31e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—NQO1—breast cancer	2.11e-06	2.31e-05	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—PTGS2—breast cancer	2.11e-06	2.3e-05	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—PIK3CA—breast cancer	2.11e-06	2.3e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—HMOX1—breast cancer	2.11e-06	2.3e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—ITPR1—breast cancer	2.1e-06	2.29e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—NQO1—breast cancer	2.1e-06	2.29e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—SLC2A1—breast cancer	2.1e-06	2.29e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—CYP3A4—breast cancer	2.06e-06	2.25e-05	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—PIK3CD—breast cancer	2.06e-06	2.24e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	2.05e-06	2.24e-05	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—PIK3CA—breast cancer	2.05e-06	2.23e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—CYP3A4—breast cancer	2.04e-06	2.23e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	2.03e-06	2.22e-05	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—MAPK3—breast cancer	2.03e-06	2.22e-05	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—ALB—breast cancer	2.03e-06	2.22e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—CYP1B1—breast cancer	2.03e-06	2.21e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—ABCB1—breast cancer	2.02e-06	2.2e-05	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—PIK3CA—breast cancer	2.02e-06	2.2e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—MTHFR—breast cancer	2.01e-06	2.2e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—CYP1B1—breast cancer	2.01e-06	2.19e-05	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—PIK3CD—breast cancer	2e-06	2.18e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—HSP90AA1—breast cancer	1.99e-06	2.17e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—TYMS—breast cancer	1.99e-06	2.17e-05	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—TGFB1—breast cancer	1.97e-06	2.15e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—HSP90AA1—breast cancer	1.97e-06	2.15e-05	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—ALB—breast cancer	1.97e-06	2.15e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—GSTM1—breast cancer	1.96e-06	2.14e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—NCOR1—breast cancer	1.96e-06	2.14e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—PLA2G4A—breast cancer	1.96e-06	2.14e-05	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—NOS3—breast cancer	1.94e-06	2.12e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—NCOA1—breast cancer	1.93e-06	2.11e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—NCOA1—breast cancer	1.92e-06	2.09e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—CYP19A1—breast cancer	1.91e-06	2.08e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—STK11—breast cancer	1.91e-06	2.08e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—CYP19A1—breast cancer	1.89e-06	2.06e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—STK11—breast cancer	1.89e-06	2.06e-05	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—NOS3—breast cancer	1.88e-06	2.05e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—MED12—breast cancer	1.88e-06	2.05e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—DPYD—breast cancer	1.88e-06	2.05e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—GPX1—breast cancer	1.88e-06	2.05e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—CYP1A1—breast cancer	1.86e-06	2.03e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—CAV1—breast cancer	1.86e-06	2.03e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—ALDOA—breast cancer	1.85e-06	2.02e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—ERCC2—breast cancer	1.85e-06	2.01e-05	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—PTEN—breast cancer	1.84e-06	2.01e-05	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—KRAS—breast cancer	1.83e-06	1.99e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—NCOA3—breast cancer	1.8e-06	1.96e-05	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—PIK3CB—breast cancer	1.79e-06	1.96e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—SLC2A2—breast cancer	1.79e-06	1.95e-05	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—PTGS2—breast cancer	1.78e-06	1.94e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—breast cancer	1.77e-06	1.93e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—COMT—breast cancer	1.77e-06	1.93e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—GSTP1—breast cancer	1.76e-06	1.92e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—COMT—breast cancer	1.76e-06	1.92e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—CPT1A—breast cancer	1.75e-06	1.91e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—MTR—breast cancer	1.75e-06	1.91e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—ABCG2—breast cancer	1.75e-06	1.91e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—GSTP1—breast cancer	1.75e-06	1.91e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—HMOX1—breast cancer	1.74e-06	1.9e-05	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—PIK3CB—breast cancer	1.74e-06	1.9e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—ITPR1—breast cancer	1.74e-06	1.89e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—MTHFR—breast cancer	1.73e-06	1.89e-05	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—AKT1—breast cancer	1.73e-06	1.88e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—HMOX1—breast cancer	1.72e-06	1.88e-05	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—PTGS2—breast cancer	1.72e-06	1.88e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—ITPR1—breast cancer	1.72e-06	1.88e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—HPGDS—breast cancer	1.72e-06	1.87e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—HBA1—breast cancer	1.7e-06	1.86e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—PIK3CG—breast cancer	1.69e-06	1.85e-05	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—PIK3CA—breast cancer	1.68e-06	1.83e-05	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—AKT1—breast cancer	1.67e-06	1.82e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—ABCB1—breast cancer	1.67e-06	1.82e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—ACHE—breast cancer	1.66e-06	1.81e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—GSTT1—breast cancer	1.66e-06	1.81e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—ABCB1—breast cancer	1.66e-06	1.8e-05	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—AKT1—breast cancer	1.65e-06	1.8e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—TYMS—breast cancer	1.64e-06	1.79e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—TYMS—breast cancer	1.63e-06	1.77e-05	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—TP53—breast cancer	1.62e-06	1.77e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—NCOR1—breast cancer	1.62e-06	1.77e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—GSTM1—breast cancer	1.62e-06	1.77e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—PLA2G4A—breast cancer	1.62e-06	1.77e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—PLA2G4A—breast cancer	1.61e-06	1.75e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—NCOR1—breast cancer	1.61e-06	1.75e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—GSTM1—breast cancer	1.61e-06	1.75e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—CAV1—breast cancer	1.6e-06	1.74e-05	CbGpPWpGaD
Nateglinide—PPARG—Gene Expression—AKT1—breast cancer	1.59e-06	1.73e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—CYP17A1—breast cancer	1.57e-06	1.72e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—ENO1—breast cancer	1.56e-06	1.7e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—PTGS1—breast cancer	1.56e-06	1.7e-05	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—HRAS—breast cancer	1.55e-06	1.69e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—GPX1—breast cancer	1.55e-06	1.69e-05	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—PTEN—breast cancer	1.55e-06	1.69e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—GPX1—breast cancer	1.54e-06	1.68e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—CYP1A1—breast cancer	1.54e-06	1.68e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.53e-06	1.67e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—CYP2D6—breast cancer	1.53e-06	1.67e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—ERCC2—breast cancer	1.52e-06	1.66e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—CYP1A1—breast cancer	1.52e-06	1.66e-05	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—PIK3CA—breast cancer	1.51e-06	1.65e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—ERCC2—breast cancer	1.51e-06	1.65e-05	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—PTEN—breast cancer	1.5e-06	1.64e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—NCOA2—breast cancer	1.5e-06	1.64e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—PIK3CD—breast cancer	1.49e-06	1.62e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—ALB—breast cancer	1.47e-06	1.6e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—PIK3CG—breast cancer	1.46e-06	1.59e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—FASN—breast cancer	1.46e-06	1.59e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—BCHE—breast cancer	1.45e-06	1.58e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—MTHFR—breast cancer	1.43e-06	1.56e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—SLC5A5—breast cancer	1.43e-06	1.56e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—MTHFR—breast cancer	1.42e-06	1.55e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—NOS3—breast cancer	1.41e-06	1.53e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—SLC2A1—breast cancer	1.38e-06	1.51e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—NQO1—breast cancer	1.38e-06	1.51e-05	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—AKT1—breast cancer	1.37e-06	1.5e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—CYP1B1—breast cancer	1.33e-06	1.45e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—CAV1—breast cancer	1.32e-06	1.44e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—CAV1—breast cancer	1.31e-06	1.43e-05	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—PIK3CA—breast cancer	1.3e-06	1.42e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—HSP90AA1—breast cancer	1.3e-06	1.42e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—PIK3CB—breast cancer	1.3e-06	1.41e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—PTGS2—breast cancer	1.29e-06	1.4e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—PIK3CD—breast cancer	1.28e-06	1.4e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—NCOA1—breast cancer	1.26e-06	1.38e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.25e-06	1.36e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—CYP19A1—breast cancer	1.25e-06	1.36e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—STK11—breast cancer	1.25e-06	1.36e-05	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—AKT1—breast cancer	1.24e-06	1.35e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—NOS3—breast cancer	1.21e-06	1.32e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—PIK3CG—breast cancer	1.2e-06	1.31e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—PIK3CG—breast cancer	1.19e-06	1.3e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—COMT—breast cancer	1.16e-06	1.26e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—GSTP1—breast cancer	1.15e-06	1.26e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—HMOX1—breast cancer	1.14e-06	1.24e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—ITPR1—breast cancer	1.13e-06	1.24e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—PTEN—breast cancer	1.12e-06	1.22e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—PIK3CB—breast cancer	1.12e-06	1.22e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—PTGS2—breast cancer	1.11e-06	1.21e-05	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—PIK3CA—breast cancer	1.09e-06	1.19e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—ABCB1—breast cancer	1.09e-06	1.19e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—TYMS—breast cancer	1.07e-06	1.17e-05	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—AKT1—breast cancer	1.06e-06	1.16e-05	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—PIK3CA—breast cancer	1.06e-06	1.16e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—PLA2G4A—breast cancer	1.06e-06	1.16e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—GSTM1—breast cancer	1.06e-06	1.16e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—NCOR1—breast cancer	1.06e-06	1.16e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—PIK3CD—breast cancer	1.06e-06	1.15e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—PIK3CD—breast cancer	1.05e-06	1.14e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—ALB—breast cancer	1.04e-06	1.14e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—ALB—breast cancer	1.04e-06	1.13e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—GPX1—breast cancer	1.01e-06	1.11e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—CYP1A1—breast cancer	1e-06	1.1e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—NOS3—breast cancer	9.99e-07	1.09e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—ERCC2—breast cancer	9.96e-07	1.09e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—NOS3—breast cancer	9.9e-07	1.08e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—PTEN—breast cancer	9.65e-07	1.05e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—MTHFR—breast cancer	9.37e-07	1.02e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—PIK3CB—breast cancer	9.22e-07	1.01e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—PIK3CB—breast cancer	9.14e-07	9.97e-06	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—PTGS2—breast cancer	9.14e-07	9.96e-06	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—PTGS2—breast cancer	9.06e-07	9.88e-06	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—AKT1—breast cancer	8.93e-07	9.74e-06	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—AKT1—breast cancer	8.66e-07	9.44e-06	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—CAV1—breast cancer	8.64e-07	9.42e-06	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—PTEN—breast cancer	7.97e-07	8.69e-06	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—PIK3CA—breast cancer	7.91e-07	8.62e-06	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—PTEN—breast cancer	7.9e-07	8.61e-06	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—PIK3CG—breast cancer	7.87e-07	8.58e-06	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—PIK3CD—breast cancer	6.92e-07	7.54e-06	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—ALB—breast cancer	6.83e-07	7.45e-06	CbGpPWpGaD
Nateglinide—ALB—Metabolism—PIK3CA—breast cancer	6.81e-07	7.42e-06	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—NOS3—breast cancer	6.53e-07	7.12e-06	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—AKT1—breast cancer	6.46e-07	7.04e-06	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—PIK3CB—breast cancer	6.03e-07	6.57e-06	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—PTGS2—breast cancer	5.97e-07	6.51e-06	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—PIK3CA—breast cancer	5.62e-07	6.13e-06	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—PIK3CA—breast cancer	5.57e-07	6.08e-06	CbGpPWpGaD
Nateglinide—ALB—Metabolism—AKT1—breast cancer	5.56e-07	6.06e-06	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—PTEN—breast cancer	5.21e-07	5.68e-06	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—AKT1—breast cancer	4.59e-07	5.01e-06	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—AKT1—breast cancer	4.55e-07	4.96e-06	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—PIK3CA—breast cancer	3.68e-07	4.01e-06	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—AKT1—breast cancer	3e-07	3.27e-06	CbGpPWpGaD
